4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-21-065696
Director bought 3,300 shares at an average $34.52 ($113,922)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saad Mark E Director | 2021-11-17 | Purchase | +3,000 | $34.53 | $103,597 | 10,002 | D |
| Saad Mark E Director | 2021-11-17 | Purchase | +100 | $34.40 | $3,440 | 100 | I |
| Saad Mark E Director | 2021-11-17 | Purchase | +100 | $34.45 | $3,445 | 100 | I |
| Saad Mark E Director | 2021-11-17 | Purchase | +100 | $34.40 | $3,440 | 100 | I |
| Open-market purchases · 3,300 sh · avg $34.52 · $113,922 | |||||||
Loading xslF345X03/doc4.xml…